Fidelis Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$6.32M |
| 2 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$4.36M |
| 3 |
Broadcom
AVGO
|
+$3.59M |
| 4 |
Oracle
ORCL
|
+$3.13M |
| 5 |
Microsoft
MSFT
|
+$2.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$1.39M |
| 2 |
Fair Isaac
FICO
|
+$859K |
| 3 |
EOG Resources
EOG
|
+$838K |
| 4 |
Fastenal
FAST
|
+$837K |
| 5 |
Colgate-Palmolive
CL
|
+$760K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.88% |
| 2 | Financials | 9.45% |
| 3 | Communication Services | 6.51% |
| 4 | Consumer Discretionary | 5.5% |
| 5 | Industrials | 5.36% |
Similar funds
Fidelis Capital Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Fidelis Capital Partners held 496 positions worth $1.28B, up 17% from $1.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Fidelis Capital Partners deployed $104M of net new capital in Q3 2025, opening 51 new positions and adding to 276 existing holdings. Its largest new stake was Avantis Emerging Markets Equity ETF: 61,049 shares worth $4.59M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $1.39M trimmed.
- Fidelis Capital Partners's largest Q3 2025 buy was Avantis Emerging Markets Equity ETF: 61,049 shares worth $4.59M.
- Fidelis Capital Partners added most to NVIDIA in Q3 2025, an estimated $6.32M increase.
- Fidelis Capital Partners's biggest Q3 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $1.39M.
- Fidelis Capital Partners fully exited SLB Ltd in Q3 2025, selling an estimated $453K.
- Fidelis Capital Partners's ten largest holdings make up 33% of its $1.28B portfolio in Q3 2025.
- Fidelis Capital Partners opened 51 new positions and closed 7 in Q3 2025.
- Fidelis Capital Partners's portfolio value rose 17% quarter-over-quarter to $1.28B.
Based on Fidelis Capital Partners's 13F filing for Q3 2025, filed 3 Nov 2025.